YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
106 hedge funds and large institutions have $819M invested in Y-mAbs Therapeutics in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
106
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$12.6M | |
| 2 | +$5.61M | |
| 3 | +$4.39M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$3.81M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.62M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$7.53M | |
| 3 | -$6.79M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.67M |
| 5 |
Two Sigma Investments
New York
|
-$2.12M |